nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.188	1	CrCtD
Epirubicin—AURKA—peripheral nervous system neoplasm	0.124	1	CbGaD
Epirubicin—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.0951	0.344	CiPCiCtD
Epirubicin—bone cancer—peripheral nervous system neoplasm	0.0774	0.587	CtDrD
Epirubicin—Anthracyclines—Doxorubicin—peripheral nervous system neoplasm	0.0773	0.28	CiPCiCtD
Epirubicin—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0634	0.23	CiPCiCtD
Epirubicin—sarcoma—peripheral nervous system neoplasm	0.0545	0.413	CtDrD
Epirubicin—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0404	0.146	CiPCiCtD
Epirubicin—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	0.0396	0.333	CrCrCtD
Epirubicin—Valrubicin—Doxorubicin—peripheral nervous system neoplasm	0.0396	0.333	CrCrCtD
Epirubicin—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.0396	0.333	CrCrCtD
Epirubicin—YWHAG—Doxorubicin—peripheral nervous system neoplasm	0.0252	0.235	CbGbCtD
Epirubicin—AURKA—Doxorubicin—peripheral nervous system neoplasm	0.0252	0.235	CbGbCtD
Epirubicin—DHCR7—Doxorubicin—peripheral nervous system neoplasm	0.0252	0.235	CbGbCtD
Epirubicin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.00751	0.0701	CbGbCtD
Epirubicin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00738	0.0688	CbGbCtD
Epirubicin—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.00512	0.0478	CbGbCtD
Epirubicin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00454	0.0424	CbGbCtD
Epirubicin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00416	0.0388	CbGbCtD
Epirubicin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00284	0.0265	CbGbCtD
Epirubicin—Doxorubicin—AURKA—peripheral nervous system neoplasm	0.000471	0.797	CrCbGaD
Epirubicin—AURKA—Chlorambucil—Melphalan—peripheral nervous system neoplasm	0.000201	0.259	CbGdCrCtD
Epirubicin—AURKA—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000139	0.18	CbGdCrCtD
Epirubicin—CHD1—trigeminal ganglion—peripheral nervous system neoplasm	0.000124	0.14	CbGeAlD
Epirubicin—CHD1—parotid gland—peripheral nervous system neoplasm	0.000117	0.132	CbGeAlD
Epirubicin—CHD1—brainstem—peripheral nervous system neoplasm	0.00011	0.124	CbGeAlD
Epirubicin—YWHAG—Membrane Trafficking—GNS—peripheral nervous system neoplasm	8.92e-05	0.0101	CbGpPWpGaD
Epirubicin—DHCR7—trigeminal ganglion—peripheral nervous system neoplasm	8.37e-05	0.0941	CbGeAlD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—MET—peripheral nervous system neoplasm	8.34e-05	0.00945	CbGpPWpGaD
Epirubicin—DHCR7—parotid gland—peripheral nervous system neoplasm	7.89e-05	0.0888	CbGeAlD
Epirubicin—YWHAG—trigeminal ganglion—peripheral nervous system neoplasm	7.68e-05	0.0863	CbGeAlD
Epirubicin—CHD1—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.099	CbGdCrCtD
Epirubicin—CHD1—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.099	CbGdCrCtD
Epirubicin—PLA2G4A—Opioid Signalling—PPP3R1—peripheral nervous system neoplasm	7.48e-05	0.00847	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—PPP3R1—peripheral nervous system neoplasm	7.34e-05	0.00832	CbGpPWpGaD
Epirubicin—YWHAG—parotid gland—peripheral nervous system neoplasm	7.24e-05	0.0814	CbGeAlD
Epirubicin—YWHAG—Activation of BAD and translocation to mitochondria—AKT1—peripheral nervous system neoplasm	7.21e-05	0.00817	CbGpPWpGaD
Epirubicin—YWHAG—G2/M Transition—AURKA—peripheral nervous system neoplasm	7.1e-05	0.00805	CbGpPWpGaD
Epirubicin—YWHAG—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	7e-05	0.00793	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CHEK2—peripheral nervous system neoplasm	6.89e-05	0.00781	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	6.65e-05	0.00753	CbGpPWpGaD
Epirubicin—Daunorubicin—ABCB1—peripheral nervous system neoplasm	6.63e-05	0.112	CrCbGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP3—peripheral nervous system neoplasm	6.33e-05	0.00718	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—peripheral nervous system neoplasm	6.31e-05	0.00714	CbGpPWpGaD
Epirubicin—ABCC1—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	6.3e-05	0.00714	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—ERBB2—peripheral nervous system neoplasm	6.1e-05	0.00691	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.06e-05	0.00686	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.96e-05	0.00675	CbGpPWpGaD
Epirubicin—PLA2G4A—trigeminal ganglion—peripheral nervous system neoplasm	5.73e-05	0.0644	CbGeAlD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—peripheral nervous system neoplasm	5.68e-05	0.00643	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—peripheral nervous system neoplasm	5.54e-05	0.00628	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	5.49e-05	0.00622	CbGpPWpGaD
Epirubicin—CHD1—cerebellum—peripheral nervous system neoplasm	5.41e-05	0.0609	CbGeAlD
Epirubicin—Doxorubicin—ABCB1—peripheral nervous system neoplasm	5.38e-05	0.091	CrCbGaD
Epirubicin—AURKA—Aurora A signaling—AKT1—peripheral nervous system neoplasm	5.33e-05	0.00603	CbGpPWpGaD
Epirubicin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	5.32e-05	0.0688	CbGdCrCtD
Epirubicin—YWHAG—Apoptosis—TNFSF10—peripheral nervous system neoplasm	5.31e-05	0.00602	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—PTPN11—peripheral nervous system neoplasm	5.24e-05	0.00594	CbGpPWpGaD
Epirubicin—AURKA—Teniposide—Etoposide—peripheral nervous system neoplasm	5.22e-05	0.0675	CbGdCrCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.16e-05	0.00585	CbGpPWpGaD
Epirubicin—PLA2G4A—Glycerophospholipid biosynthesis—BCHE—peripheral nervous system neoplasm	5.12e-05	0.0058	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	5.03e-05	0.0057	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—AKT1—peripheral nervous system neoplasm	4.79e-05	0.00543	CbGpPWpGaD
Epirubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—peripheral nervous system neoplasm	4.78e-05	0.00542	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—MYC—peripheral nervous system neoplasm	4.48e-05	0.00507	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—GNAS—peripheral nervous system neoplasm	4.33e-05	0.00491	CbGpPWpGaD
Epirubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	4.31e-05	0.00488	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	4.26e-05	0.00482	CbGpPWpGaD
Epirubicin—YWHAG—Insulin-mediated glucose transport—AKT1—peripheral nervous system neoplasm	4.26e-05	0.00482	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	4.13e-05	0.00467	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	4.1e-05	0.00464	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.09e-05	0.00463	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—MYC—peripheral nervous system neoplasm	4.07e-05	0.00461	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—peripheral nervous system neoplasm	4.06e-05	0.0046	CbGpPWpGaD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—peripheral nervous system neoplasm	4.06e-05	0.00459	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—peripheral nervous system neoplasm	4.02e-05	0.00456	CbGpPWpGaD
Epirubicin—AURKA—Integrin-linked kinase signaling—AKT1—peripheral nervous system neoplasm	3.95e-05	0.00448	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	3.94e-05	0.00446	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—peripheral nervous system neoplasm	3.68e-05	0.00417	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PTPN11—peripheral nervous system neoplasm	3.66e-05	0.00415	CbGpPWpGaD
Epirubicin—YWHAG—Class I PI3K signaling events mediated by Akt—AKT1—peripheral nervous system neoplasm	3.66e-05	0.00415	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	3.65e-05	0.00414	CbGpPWpGaD
Epirubicin—DHCR7—cerebellum—peripheral nervous system neoplasm	3.65e-05	0.0411	CbGeAlD
Epirubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—peripheral nervous system neoplasm	3.58e-05	0.00406	CbGpPWpGaD
Epirubicin—PLA2G4A—Phospholipid metabolism—BCHE—peripheral nervous system neoplasm	3.57e-05	0.00405	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—AKT1—peripheral nervous system neoplasm	3.43e-05	0.00389	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—NRAS—peripheral nervous system neoplasm	3.41e-05	0.00387	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	3.41e-05	0.00386	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.4e-05	0.00385	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—peripheral nervous system neoplasm	3.39e-05	0.00384	CbGpPWpGaD
Epirubicin—YWHAG—cerebellum—peripheral nervous system neoplasm	3.35e-05	0.0377	CbGeAlD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—peripheral nervous system neoplasm	3.34e-05	0.00379	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	3.32e-05	0.00377	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.31e-05	0.00375	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	3.27e-05	0.00371	CbGpPWpGaD
Epirubicin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	3.16e-05	0.0409	CbGdCrCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.11e-05	0.00352	CbGpPWpGaD
Epirubicin—ABCC1—parotid gland—peripheral nervous system neoplasm	3.09e-05	0.0347	CbGeAlD
Epirubicin—PLA2G4A—Platelet homeostasis—PTPN11—peripheral nervous system neoplasm	3.01e-05	0.00341	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	3e-05	0.00339	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNS—peripheral nervous system neoplasm	2.96e-05	0.00335	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.92e-05	0.00331	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	2.89e-05	0.00327	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	2.87e-05	0.00325	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NME1—peripheral nervous system neoplasm	2.84e-05	0.00321	CbGpPWpGaD
Epirubicin—YWHAG—FoxO family signaling—AKT1—peripheral nervous system neoplasm	2.8e-05	0.00317	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.77e-05	0.00314	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—COX2—peripheral nervous system neoplasm	2.73e-05	0.00309	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—peripheral nervous system neoplasm	2.73e-05	0.00309	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.66e-05	0.00301	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	2.63e-05	0.00298	CbGpPWpGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—peripheral nervous system neoplasm	2.57e-05	0.00291	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	2.55e-05	0.00289	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.55e-05	0.00289	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.53e-05	0.00287	CbGpPWpGaD
Epirubicin—AURKA—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.0326	CbGdCrCtD
Epirubicin—AURKA—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.0326	CbGdCrCtD
Epirubicin—YWHAG—mTOR signaling pathway—HRAS—peripheral nervous system neoplasm	2.5e-05	0.00283	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.48e-05	0.00281	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—CASP3—peripheral nervous system neoplasm	2.47e-05	0.0028	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.44e-05	0.00276	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	2.4e-05	0.00271	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CHEK2—peripheral nervous system neoplasm	2.38e-05	0.0027	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—NRAS—peripheral nervous system neoplasm	2.35e-05	0.00267	CbGpPWpGaD
Epirubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—AKT1—peripheral nervous system neoplasm	2.35e-05	0.00266	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.31e-05	0.00261	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGF Pathway—HRAS—peripheral nervous system neoplasm	2.3e-05	0.00261	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	2.26e-05	0.00256	CbGpPWpGaD
Epirubicin—YWHAG—mTOR signaling pathway—AKT1—peripheral nervous system neoplasm	2.2e-05	0.0025	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.16e-05	0.00245	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	2.15e-05	0.00244	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.11e-05	0.00239	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.09e-05	0.00237	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	2.08e-05	0.00235	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—PTPN11—peripheral nervous system neoplasm	2.06e-05	0.00234	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—CASP3—peripheral nervous system neoplasm	2.06e-05	0.00233	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.05e-05	0.00232	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	2.05e-05	0.00232	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.05e-05	0.00232	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—AURKA—peripheral nervous system neoplasm	2.02e-05	0.00229	CbGpPWpGaD
Epirubicin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	2e-05	0.0258	CbGdCrCtD
Epirubicin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	1.99e-05	0.0258	CbGdCrCtD
Epirubicin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	1.99e-05	0.0258	CbGdCrCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.93e-05	0.00219	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	1.91e-05	0.00216	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	1.85e-05	0.0021	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—peripheral nervous system neoplasm	1.84e-05	0.00209	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1.81e-05	0.00205	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	1.79e-05	0.00203	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ENO2—peripheral nervous system neoplasm	1.79e-05	0.00203	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	1.78e-05	0.00202	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	1.78e-05	0.00201	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.73e-05	0.00196	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—HRAS—peripheral nervous system neoplasm	1.72e-05	0.00195	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.64e-05	0.00186	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—peripheral nervous system neoplasm	1.61e-05	0.00183	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	1.61e-05	0.00182	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	1.58e-05	0.00179	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.58e-05	0.00179	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—HRAS—peripheral nervous system neoplasm	1.57e-05	0.00178	CbGpPWpGaD
Epirubicin—YWHAG—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-05	0.00172	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—BCHE—peripheral nervous system neoplasm	1.51e-05	0.00172	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.5e-05	0.0017	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	1.5e-05	0.0017	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.46e-05	0.00166	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	1.46e-05	0.00166	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.00164	CbGpPWpGaD
Epirubicin—ABCC1—cerebellum—peripheral nervous system neoplasm	1.43e-05	0.0161	CbGeAlD
Epirubicin—DHCR7—Metabolism—TH—peripheral nervous system neoplasm	1.42e-05	0.00161	CbGpPWpGaD
Epirubicin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—peripheral nervous system neoplasm	1.42e-05	0.00161	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	1.42e-05	0.00161	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	1.42e-05	0.00161	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	1.41e-05	0.0016	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.41e-05	0.0016	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—AKT1—peripheral nervous system neoplasm	1.39e-05	0.00157	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.38e-05	0.00157	CbGpPWpGaD
Epirubicin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	1.37e-05	0.0177	CbGdCrCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	1.36e-05	0.00154	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.34e-05	0.00152	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—AKT1—peripheral nervous system neoplasm	1.34e-05	0.00151	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—peripheral nervous system neoplasm	1.32e-05	0.00149	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.31e-05	0.00148	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.28e-05	0.00145	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1.26e-05	0.00143	CbGpPWpGaD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	1.25e-05	0.00142	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—peripheral nervous system neoplasm	1.24e-05	0.00141	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.22e-05	0.00138	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.2e-05	0.00136	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GNAS—peripheral nervous system neoplasm	1.16e-05	0.00132	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.16e-05	0.00132	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MYC—peripheral nervous system neoplasm	1.16e-05	0.00131	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.15e-05	0.0013	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.15e-05	0.0013	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.14e-05	0.00129	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—AKT1—peripheral nervous system neoplasm	1.11e-05	0.00126	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—KNG1—peripheral nervous system neoplasm	1.11e-05	0.00126	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.11e-05	0.00125	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.07e-05	0.00122	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.05e-05	0.00119	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.02e-05	0.00116	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	1.02e-05	0.00116	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNS—peripheral nervous system neoplasm	1e-05	0.00113	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.91e-06	0.00112	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	9.79e-06	0.00111	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	9.71e-06	0.0011	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GNAS—peripheral nervous system neoplasm	9.7e-06	0.0011	CbGpPWpGaD
Epirubicin—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	9.62e-06	0.0124	CbGdCrCtD
Epirubicin—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	9.62e-06	0.0124	CbGdCrCtD
Epirubicin—PLA2G4A—Metabolism—NME1—peripheral nervous system neoplasm	9.6e-06	0.00109	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GNS—peripheral nervous system neoplasm	9.55e-06	0.00108	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.5e-06	0.00108	CbGpPWpGaD
Epirubicin—YWHAG—Membrane Trafficking—AKT1—peripheral nervous system neoplasm	9.46e-06	0.00107	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	9.42e-06	0.00107	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—HGF—peripheral nervous system neoplasm	9.24e-06	0.00105	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—COX2—peripheral nervous system neoplasm	9.24e-06	0.00105	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.19e-06	0.00104	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	9.16e-06	0.00104	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—peripheral nervous system neoplasm	9.08e-06	0.00103	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	8.68e-06	0.000983	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	8.68e-06	0.000983	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.37e-06	0.000948	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.34e-06	0.000945	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.23e-06	0.000933	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.03e-06	0.000909	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	8e-06	0.000906	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.8e-06	0.000884	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—peripheral nervous system neoplasm	7.76e-06	0.000879	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	7.67e-06	0.000869	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.49e-06	0.000849	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	7.38e-06	0.000836	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	6.79e-06	0.000769	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.76e-06	0.000766	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.74e-06	0.000764	CbGpPWpGaD
Epirubicin—Fatigue—Vincristine—peripheral nervous system neoplasm	6.71e-06	0.000156	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.71e-06	0.00076	CbGpPWpGaD
Epirubicin—Convulsion—Etoposide—peripheral nervous system neoplasm	6.69e-06	0.000156	CcSEcCtD
Epirubicin—Vomiting—Melphalan—peripheral nervous system neoplasm	6.69e-06	0.000155	CcSEcCtD
Epirubicin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	6.69e-06	0.000155	CcSEcCtD
Epirubicin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	6.68e-06	0.000155	CcSEcCtD
Epirubicin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	6.68e-06	0.000757	CbGpPWpGaD
Epirubicin—Headache—Isotretinoin—peripheral nervous system neoplasm	6.68e-06	0.000155	CcSEcCtD
Epirubicin—Headache—Tretinoin—peripheral nervous system neoplasm	6.68e-06	0.000155	CcSEcCtD
Epirubicin—Hypertension—Etoposide—peripheral nervous system neoplasm	6.67e-06	0.000155	CcSEcCtD
Epirubicin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	6.66e-06	0.000155	CcSEcCtD
Epirubicin—Constipation—Vincristine—peripheral nervous system neoplasm	6.66e-06	0.000155	CcSEcCtD
Epirubicin—Pain—Vincristine—peripheral nervous system neoplasm	6.66e-06	0.000155	CcSEcCtD
Epirubicin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	6.65e-06	0.000155	CcSEcCtD
Epirubicin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	6.65e-06	0.000155	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.65e-06	0.000155	CcSEcCtD
Epirubicin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	6.65e-06	0.000155	CcSEcCtD
Epirubicin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	6.65e-06	0.000155	CcSEcCtD
Epirubicin—Rash—Melphalan—peripheral nervous system neoplasm	6.63e-06	0.000154	CcSEcCtD
Epirubicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	6.63e-06	0.000154	CcSEcCtD
Epirubicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	6.61e-06	0.000154	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.59e-06	0.000747	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.58e-06	0.000746	CbGpPWpGaD
Epirubicin—Chest pain—Etoposide—peripheral nervous system neoplasm	6.58e-06	0.000153	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	6.58e-06	0.000745	CbGpPWpGaD
Epirubicin—Anorexia—Cisplatin—peripheral nervous system neoplasm	6.56e-06	0.000153	CcSEcCtD
Epirubicin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	6.55e-06	0.000152	CcSEcCtD
Epirubicin—Migraine—Doxorubicin—peripheral nervous system neoplasm	6.55e-06	0.000152	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	6.53e-06	0.000152	CcSEcCtD
Epirubicin—Discomfort—Etoposide—peripheral nervous system neoplasm	6.5e-06	0.000151	CcSEcCtD
Epirubicin—Hypotension—Cisplatin—peripheral nervous system neoplasm	6.43e-06	0.00015	CcSEcCtD
Epirubicin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	6.42e-06	0.000149	CcSEcCtD
Epirubicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	6.42e-06	0.000149	CcSEcCtD
Epirubicin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	6.42e-06	0.000149	CcSEcCtD
Epirubicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	6.39e-06	0.000148	CcSEcCtD
Epirubicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	6.39e-06	0.000148	CcSEcCtD
Epirubicin—Nausea—Topotecan—peripheral nervous system neoplasm	6.38e-06	0.000148	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—TP53—peripheral nervous system neoplasm	6.37e-06	0.000722	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.37e-06	0.000721	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	6.37e-06	0.000148	CcSEcCtD
Epirubicin—Confusional state—Etoposide—peripheral nervous system neoplasm	6.36e-06	0.000148	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.34e-06	0.000719	CbGpPWpGaD
Epirubicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	6.33e-06	0.000147	CcSEcCtD
Epirubicin—Nausea—Tretinoin—peripheral nervous system neoplasm	6.33e-06	0.000147	CcSEcCtD
Epirubicin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	6.33e-06	0.000147	CcSEcCtD
Epirubicin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	6.31e-06	0.000147	CcSEcCtD
Epirubicin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	6.3e-06	0.000147	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	6.27e-06	0.000146	CcSEcCtD
Epirubicin—Infection—Etoposide—peripheral nervous system neoplasm	6.27e-06	0.000146	CcSEcCtD
Epirubicin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	6.26e-06	0.000145	CcSEcCtD
Epirubicin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	6.25e-06	0.000145	CcSEcCtD
Epirubicin—Nausea—Melphalan—peripheral nervous system neoplasm	6.25e-06	0.000145	CcSEcCtD
Epirubicin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	6.23e-06	0.000145	CcSEcCtD
Epirubicin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	6.19e-06	0.000144	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	6.18e-06	0.000701	CbGpPWpGaD
Epirubicin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	6.18e-06	0.000144	CcSEcCtD
Epirubicin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	6.17e-06	0.000144	CcSEcCtD
Epirubicin—Tachycardia—Etoposide—peripheral nervous system neoplasm	6.15e-06	0.000143	CcSEcCtD
Epirubicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	6.15e-06	0.000143	CcSEcCtD
Epirubicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.15e-06	0.000143	CcSEcCtD
Epirubicin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	6.14e-06	0.000143	CcSEcCtD
Epirubicin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	6.14e-06	0.000143	CcSEcCtD
Epirubicin—Skin disorder—Etoposide—peripheral nervous system neoplasm	6.13e-06	0.000142	CcSEcCtD
Epirubicin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	6.1e-06	0.000142	CcSEcCtD
Epirubicin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	6.1e-06	0.000142	CcSEcCtD
Epirubicin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	6.08e-06	0.000141	CcSEcCtD
Epirubicin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	6.08e-06	0.000141	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	6.07e-06	0.000688	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ENO2—peripheral nervous system neoplasm	6.07e-06	0.000687	CbGpPWpGaD
Epirubicin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	6.06e-06	0.000141	CcSEcCtD
Epirubicin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	6.01e-06	0.00014	CcSEcCtD
Epirubicin—Anorexia—Etoposide—peripheral nervous system neoplasm	6.01e-06	0.00014	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	5.99e-06	0.000139	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	5.99e-06	0.000139	CcSEcCtD
Epirubicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	5.98e-06	0.000139	CcSEcCtD
Epirubicin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.96e-06	0.000139	CcSEcCtD
Epirubicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	5.95e-06	0.000138	CcSEcCtD
Epirubicin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	5.95e-06	0.000138	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.94e-06	0.000138	CcSEcCtD
Epirubicin—Hypotension—Etoposide—peripheral nervous system neoplasm	5.89e-06	0.000137	CcSEcCtD
Epirubicin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	5.89e-06	0.000137	CcSEcCtD
Epirubicin—Pain—Cisplatin—peripheral nervous system neoplasm	5.89e-06	0.000137	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—MYC—peripheral nervous system neoplasm	5.88e-06	0.000666	CbGpPWpGaD
Epirubicin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	5.87e-06	0.000136	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	5.87e-06	0.000136	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.85e-06	0.000663	CbGpPWpGaD
Epirubicin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	5.8e-06	0.000135	CcSEcCtD
Epirubicin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	5.79e-06	0.000135	CcSEcCtD
Epirubicin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	5.79e-06	0.000656	CbGpPWpGaD
Epirubicin—Asthma—Doxorubicin—peripheral nervous system neoplasm	5.75e-06	0.000134	CcSEcCtD
Epirubicin—Influenza—Doxorubicin—peripheral nervous system neoplasm	5.75e-06	0.000134	CcSEcCtD
Epirubicin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	5.75e-06	0.000134	CcSEcCtD
Epirubicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	5.74e-06	0.000133	CcSEcCtD
Epirubicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	5.72e-06	0.000133	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.71e-06	0.000647	CbGpPWpGaD
Epirubicin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	5.69e-06	0.000132	CcSEcCtD
Epirubicin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.67e-06	0.000132	CcSEcCtD
Epirubicin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.66e-06	0.000132	CcSEcCtD
Epirubicin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	5.64e-06	0.000131	CcSEcCtD
Epirubicin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	5.62e-06	0.000131	CcSEcCtD
Epirubicin—Somnolence—Etoposide—peripheral nervous system neoplasm	5.61e-06	0.00013	CcSEcCtD
Epirubicin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	5.6e-06	0.00013	CcSEcCtD
Epirubicin—Asthenia—Vincristine—peripheral nervous system neoplasm	5.59e-06	0.00013	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.57e-06	0.000631	CbGpPWpGaD
Epirubicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.54e-06	0.000129	CcSEcCtD
Epirubicin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.53e-06	0.000129	CcSEcCtD
Epirubicin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.53e-06	0.000128	CcSEcCtD
Epirubicin—Rash—Dactinomycin—peripheral nervous system neoplasm	5.49e-06	0.000128	CcSEcCtD
Epirubicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.48e-06	0.000127	CcSEcCtD
Epirubicin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.46e-06	0.000127	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.44e-06	0.000127	CcSEcCtD
Epirubicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.44e-06	0.000126	CcSEcCtD
Epirubicin—Fatigue—Etoposide—peripheral nervous system neoplasm	5.44e-06	0.000126	CcSEcCtD
Epirubicin—Pain—Etoposide—peripheral nervous system neoplasm	5.39e-06	0.000125	CcSEcCtD
Epirubicin—Constipation—Etoposide—peripheral nervous system neoplasm	5.39e-06	0.000125	CcSEcCtD
Epirubicin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	5.38e-06	0.000125	CcSEcCtD
Epirubicin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	5.38e-06	0.000125	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	5.35e-06	0.000124	CcSEcCtD
Epirubicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.34e-06	0.000124	CcSEcCtD
Epirubicin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.33e-06	0.000124	CcSEcCtD
Epirubicin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	5.31e-06	0.000123	CcSEcCtD
Epirubicin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	5.25e-06	0.000122	CcSEcCtD
Epirubicin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	5.23e-06	0.000122	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	5.23e-06	0.000592	CbGpPWpGaD
Epirubicin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.2e-06	0.000121	CcSEcCtD
Epirubicin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.2e-06	0.000121	CcSEcCtD
Epirubicin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.19e-06	0.000121	CcSEcCtD
Epirubicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.18e-06	0.00012	CcSEcCtD
Epirubicin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5.16e-06	0.00012	CcSEcCtD
Epirubicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.16e-06	0.00012	CcSEcCtD
Epirubicin—Dizziness—Vincristine—peripheral nervous system neoplasm	5.15e-06	0.00012	CcSEcCtD
Epirubicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.14e-06	0.000119	CcSEcCtD
Epirubicin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	5.13e-06	0.000119	CcSEcCtD
Epirubicin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	5.13e-06	0.000119	CcSEcCtD
Epirubicin—Infestation—Doxorubicin—peripheral nervous system neoplasm	5.13e-06	0.000119	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—BCHE—peripheral nervous system neoplasm	5.12e-06	0.000581	CbGpPWpGaD
Epirubicin—Rash—Alitretinoin—peripheral nervous system neoplasm	5.09e-06	0.000118	CcSEcCtD
Epirubicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.09e-06	0.000118	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	5.08e-06	0.000118	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.08e-06	0.000576	CbGpPWpGaD
Epirubicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.07e-06	0.000118	CcSEcCtD
Epirubicin—Headache—Alitretinoin—peripheral nervous system neoplasm	5.06e-06	0.000118	CcSEcCtD
Epirubicin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	5.04e-06	0.000117	CcSEcCtD
Epirubicin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.03e-06	0.000117	CcSEcCtD
Epirubicin—Urticaria—Etoposide—peripheral nervous system neoplasm	5.01e-06	0.000116	CcSEcCtD
Epirubicin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5e-06	0.000116	CcSEcCtD
Epirubicin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5e-06	0.000116	CcSEcCtD
Epirubicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.99e-06	0.000116	CcSEcCtD
Epirubicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.99e-06	0.000116	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.99e-06	0.000565	CbGpPWpGaD
Epirubicin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	4.99e-06	0.000116	CcSEcCtD
Epirubicin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	4.99e-06	0.000116	CcSEcCtD
Epirubicin—Vomiting—Vincristine—peripheral nervous system neoplasm	4.95e-06	0.000115	CcSEcCtD
Epirubicin—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.94e-06	0.000115	CcSEcCtD
Epirubicin—Sweating—Doxorubicin—peripheral nervous system neoplasm	4.92e-06	0.000114	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	4.91e-06	0.000557	CbGpPWpGaD
Epirubicin—Rash—Vincristine—peripheral nervous system neoplasm	4.91e-06	0.000114	CcSEcCtD
Epirubicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.9e-06	0.000114	CcSEcCtD
Epirubicin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	4.89e-06	0.000114	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.89e-06	0.000554	CbGpPWpGaD
Epirubicin—Headache—Vincristine—peripheral nervous system neoplasm	4.88e-06	0.000113	CcSEcCtD
Epirubicin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	4.85e-06	0.000113	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	4.85e-06	0.000549	CbGpPWpGaD
Epirubicin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	4.84e-06	0.000112	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—peripheral nervous system neoplasm	4.83e-06	0.000547	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—TH—peripheral nervous system neoplasm	4.82e-06	0.000546	CbGpPWpGaD
Epirubicin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.81e-06	0.000112	CcSEcCtD
Epirubicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.8e-06	0.000112	CcSEcCtD
Epirubicin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.79e-06	0.000111	CcSEcCtD
Epirubicin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.71e-06	0.000109	CcSEcCtD
Epirubicin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.69e-06	0.000109	CcSEcCtD
Epirubicin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	4.66e-06	0.000528	CbGpPWpGaD
Epirubicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.65e-06	0.000108	CcSEcCtD
Epirubicin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.63e-06	0.000108	CcSEcCtD
Epirubicin—Nausea—Vincristine—peripheral nervous system neoplasm	4.62e-06	0.000107	CcSEcCtD
Epirubicin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.62e-06	0.000107	CcSEcCtD
Epirubicin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.6e-06	0.000107	CcSEcCtD
Epirubicin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.6e-06	0.000107	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.6e-06	0.000521	CbGpPWpGaD
Epirubicin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	4.58e-06	0.000106	CcSEcCtD
Epirubicin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.57e-06	0.000106	CcSEcCtD
Epirubicin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.55e-06	0.000106	CcSEcCtD
Epirubicin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.54e-06	0.000105	CcSEcCtD
Epirubicin—Asthenia—Etoposide—peripheral nervous system neoplasm	4.52e-06	0.000105	CcSEcCtD
Epirubicin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.52e-06	0.000105	CcSEcCtD
Epirubicin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.51e-06	0.000105	CcSEcCtD
Epirubicin—Pruritus—Etoposide—peripheral nervous system neoplasm	4.46e-06	0.000104	CcSEcCtD
Epirubicin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.44e-06	0.000103	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.4e-06	0.000498	CbGpPWpGaD
Epirubicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.38e-06	0.000102	CcSEcCtD
Epirubicin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.35e-06	0.000101	CcSEcCtD
Epirubicin—Rash—Cisplatin—peripheral nervous system neoplasm	4.34e-06	0.000101	CcSEcCtD
Epirubicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.34e-06	0.000101	CcSEcCtD
Epirubicin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.31e-06	0.0001	CcSEcCtD
Epirubicin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.3e-06	0.0001	CcSEcCtD
Epirubicin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.29e-06	9.98e-05	CcSEcCtD
Epirubicin—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.27e-06	9.93e-05	CcSEcCtD
Epirubicin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	4.27e-06	9.93e-05	CcSEcCtD
Epirubicin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.18e-06	9.71e-05	CcSEcCtD
Epirubicin—Dizziness—Etoposide—peripheral nervous system neoplasm	4.17e-06	9.69e-05	CcSEcCtD
Epirubicin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.16e-06	9.67e-05	CcSEcCtD
Epirubicin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.15e-06	9.64e-05	CcSEcCtD
Epirubicin—Chills—Doxorubicin—peripheral nervous system neoplasm	4.13e-06	9.6e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	4.11e-06	0.000466	CbGpPWpGaD
Epirubicin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.11e-06	9.56e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	4.09e-06	0.000464	CbGpPWpGaD
Epirubicin—Nausea—Cisplatin—peripheral nervous system neoplasm	4.09e-06	9.5e-05	CcSEcCtD
Epirubicin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.07e-06	9.46e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—NRAS—peripheral nervous system neoplasm	4.05e-06	0.000459	CbGpPWpGaD
Epirubicin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.03e-06	9.37e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	4.01e-06	0.000454	CbGpPWpGaD
Epirubicin—Vomiting—Etoposide—peripheral nervous system neoplasm	4.01e-06	9.32e-05	CcSEcCtD
Epirubicin—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.01e-06	9.32e-05	CcSEcCtD
Epirubicin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.01e-06	9.32e-05	CcSEcCtD
Epirubicin—Rash—Etoposide—peripheral nervous system neoplasm	3.98e-06	9.24e-05	CcSEcCtD
Epirubicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.97e-06	9.23e-05	CcSEcCtD
Epirubicin—Headache—Etoposide—peripheral nervous system neoplasm	3.95e-06	9.18e-05	CcSEcCtD
Epirubicin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	3.95e-06	9.18e-05	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	3.94e-06	0.000446	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GNAS—peripheral nervous system neoplasm	3.93e-06	0.000446	CbGpPWpGaD
Epirubicin—Tension—Doxorubicin—peripheral nervous system neoplasm	3.93e-06	9.14e-05	CcSEcCtD
Epirubicin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	3.92e-06	9.12e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.91e-06	0.000443	CbGpPWpGaD
Epirubicin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	3.89e-06	9.05e-05	CcSEcCtD
Epirubicin—Back pain—Doxorubicin—peripheral nervous system neoplasm	3.88e-06	9.01e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.87e-06	0.000438	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCB1—peripheral nervous system neoplasm	3.86e-06	0.000437	CbGpPWpGaD
Epirubicin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	3.85e-06	8.96e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	3.85e-06	0.000436	CbGpPWpGaD
Epirubicin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.78e-06	8.78e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.76e-06	0.000426	CbGpPWpGaD
Epirubicin—Nausea—Etoposide—peripheral nervous system neoplasm	3.75e-06	8.71e-05	CcSEcCtD
Epirubicin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.72e-06	8.64e-05	CcSEcCtD
Epirubicin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.7e-06	8.61e-05	CcSEcCtD
Epirubicin—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.68e-06	8.56e-05	CcSEcCtD
Epirubicin—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.61e-06	8.4e-05	CcSEcCtD
Epirubicin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.6e-06	8.37e-05	CcSEcCtD
Epirubicin—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.59e-06	8.35e-05	CcSEcCtD
Epirubicin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.59e-06	8.34e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.58e-06	0.000406	CbGpPWpGaD
Epirubicin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	3.54e-06	8.23e-05	CcSEcCtD
Epirubicin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.52e-06	8.19e-05	CcSEcCtD
Epirubicin—Cough—Doxorubicin—peripheral nervous system neoplasm	3.5e-06	8.13e-05	CcSEcCtD
Epirubicin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.47e-06	8.07e-05	CcSEcCtD
Epirubicin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.46e-06	8.04e-05	CcSEcCtD
Epirubicin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.41e-06	7.93e-05	CcSEcCtD
Epirubicin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.41e-06	7.93e-05	CcSEcCtD
Epirubicin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.41e-06	7.93e-05	CcSEcCtD
Epirubicin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.4e-06	7.9e-05	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.39e-06	7.88e-05	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	3.38e-06	0.000383	CbGpPWpGaD
Epirubicin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.37e-06	7.84e-05	CcSEcCtD
Epirubicin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.34e-06	7.76e-05	CcSEcCtD
Epirubicin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.3e-06	7.67e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.29e-06	0.000373	CbGpPWpGaD
Epirubicin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.27e-06	7.6e-05	CcSEcCtD
Epirubicin—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.27e-06	7.6e-05	CcSEcCtD
Epirubicin—Infection—Doxorubicin—peripheral nervous system neoplasm	3.25e-06	7.55e-05	CcSEcCtD
Epirubicin—Shock—Doxorubicin—peripheral nervous system neoplasm	3.22e-06	7.48e-05	CcSEcCtD
Epirubicin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.21e-06	7.46e-05	CcSEcCtD
Epirubicin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.2e-06	7.44e-05	CcSEcCtD
Epirubicin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.19e-06	7.42e-05	CcSEcCtD
Epirubicin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.18e-06	7.38e-05	CcSEcCtD
Epirubicin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.16e-06	7.35e-05	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-06	0.000356	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—peripheral nervous system neoplasm	3.14e-06	0.000355	CbGpPWpGaD
Epirubicin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.12e-06	7.25e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—TP53—peripheral nervous system neoplasm	3.1e-06	0.000351	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.08e-06	0.000349	CbGpPWpGaD
Epirubicin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.06e-06	7.1e-05	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.98e-06	6.93e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.97e-06	0.000336	CbGpPWpGaD
Epirubicin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.96e-06	6.88e-05	CcSEcCtD
Epirubicin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.94e-06	6.83e-05	CcSEcCtD
Epirubicin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	2.92e-06	6.78e-05	CcSEcCtD
Epirubicin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	2.91e-06	6.76e-05	CcSEcCtD
Epirubicin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.88e-06	6.69e-05	CcSEcCtD
Epirubicin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.84e-06	6.61e-05	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.82e-06	6.56e-05	CcSEcCtD
Epirubicin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.82e-06	6.55e-05	CcSEcCtD
Epirubicin—Pain—Doxorubicin—peripheral nervous system neoplasm	2.8e-06	6.5e-05	CcSEcCtD
Epirubicin—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.8e-06	6.5e-05	CcSEcCtD
Epirubicin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.7e-06	6.26e-05	CcSEcCtD
Epirubicin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.67e-06	6.22e-05	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.62e-06	0.000297	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	2.61e-06	0.000295	CbGpPWpGaD
Epirubicin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.6e-06	6.04e-05	CcSEcCtD
Epirubicin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.59e-06	6.01e-05	CcSEcCtD
Epirubicin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.59e-06	6.01e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.41e-06	5.6e-05	CcSEcCtD
Epirubicin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.35e-06	5.45e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.33e-06	0.000264	CbGpPWpGaD
Epirubicin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.31e-06	5.38e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.29e-06	0.000259	CbGpPWpGaD
Epirubicin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.24e-06	5.2e-05	CcSEcCtD
Epirubicin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.16e-06	5.03e-05	CcSEcCtD
Epirubicin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.08e-06	4.83e-05	CcSEcCtD
Epirubicin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.06e-06	4.79e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	2.06e-06	0.000234	CbGpPWpGaD
Epirubicin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.06e-06	4.79e-05	CcSEcCtD
Epirubicin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.05e-06	4.76e-05	CcSEcCtD
Epirubicin—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.94e-06	4.52e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.81e-06	0.000205	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.7e-06	0.000193	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.64e-06	0.000186	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	1.57e-06	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.5e-06	0.00017	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	1.46e-06	0.000165	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.37e-06	0.000156	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.28e-06	0.000145	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	1.15e-06	0.00013	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-06	0.000123	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—peripheral nervous system neoplasm	1.06e-06	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.05e-06	0.000119	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	1.01e-06	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.01e-06	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.88e-07	0.000101	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	8.48e-07	9.61e-05	CbGpPWpGaD
